Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Avidity Biosciences Inc stock (RNA)

Buy Avidity Biosciences Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Avidity Biosciences Inc is a biotechnology business based in the US. Avidity Biosciences Inc shares (RNA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $45.11 – a decrease of 3.43% over the previous week. Avidity Biosciences Inc employs 253 staff and has a trailing 12-month revenue of around $10.6 million.

Our top picks for where to buy Avidity Biosciences Inc stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

How to buy Avidity Biosciences Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RNA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Avidity Biosciences Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Avidity Biosciences Inc stock price (NASDAQ: RNA)

Use our graph to track the performance of RNA stocks over time.

Avidity Biosciences Inc shares at a glance

Information last updated 2024-10-25.
Latest market close$45.11
52-week range$4.83 - $50.78
50-day moving average $44.49
200-day moving average $31.61
Wall St. target price$68.09
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-2.95

Is it a good time to buy Avidity Biosciences Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avidity Biosciences Inc price performance over time

Historical closes compared with the close of $45.11 from 2024-10-25

1 week (2024-10-22) -4.79%
1 month (2024-09-27) 6.57%
3 months (2024-07-29) -2.84%
6 months (2024-04-29) 82.63%
1 year (2023-10-27) 826.28%
2 years (2022-10-25) N/A
3 years (2021-10-29) 100.49%
5 years (2019-10-25) N/A

Avidity Biosciences Inc financials

Revenue TTM $10.6 million
Gross profit TTM $-141,180,000
Return on assets TTM -18.2%
Return on equity TTM -28.36%
Profit margin 0%
Book value $11.18
Market Capitalization $5.4 billion

TTM: trailing 12 months

Avidity Biosciences Inc share dividends

We're not expecting Avidity Biosciences Inc to pay a dividend over the next 12 months.

Avidity Biosciences Inc share price volatility

Over the last 12 months, Avidity Biosciences Inc's shares have ranged in value from as little as $4.825 up to $50.78. A popular way to gauge a stock's volatility is its "beta".

RNA.US volatility(beta: 0.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avidity Biosciences Inc's is 0.891. This would suggest that Avidity Biosciences Inc's shares are less volatile than average (for this exchange).

Avidity Biosciences Inc overview

Avidity Biosciences, Inc. , a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc.

Frequently asked questions

null
What percentage of Avidity Biosciences Inc is owned by insiders or institutions?
Currently 4.93% of Avidity Biosciences Inc shares are held by insiders and 97.105% by institutions.
How many people work for Avidity Biosciences Inc?
Latest data suggests 253 work at Avidity Biosciences Inc.
When does the fiscal year end for Avidity Biosciences Inc?
Avidity Biosciences Inc's fiscal year ends in December.
Where is Avidity Biosciences Inc based?
Avidity Biosciences Inc's address is: 10578 Science Center Drive, San Diego, CA, United States, 92121
What is Avidity Biosciences Inc's ISIN number?
Avidity Biosciences Inc's international securities identification number is: US05370A1088
What is Avidity Biosciences Inc's CUSIP number?
Avidity Biosciences Inc's Committee on Uniform Securities Identification Procedures number is: N71546100

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site